180 related articles for article (PubMed ID: 8481519)
1. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome.
Chen CS; Sorensen PH; Domer PH; Reaman GH; Korsmeyer SJ; Heerema NA; Hammond GD; Kersey JH
Blood; 1993 May; 81(9):2386-93. PubMed ID: 8481519
[TBL] [Abstract][Full Text] [Related]
2. Acute lymphoblastic leukemias with deletion of 11q23 or a novel inversion (11)(p13q23) lack MLL gene rearrangements and have favorable clinical features.
Raimondi SC; Frestedt JL; Pui CH; Downing JR; Head DR; Kersey JH; Behm FG
Blood; 1995 Sep; 86(5):1881-6. PubMed ID: 7655016
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance and frequency of the 11q23/MLL genetic molecular alteration in Chilean infants with acute leukemia].
Cabrera ME; Campbell M; Quintana J; Undurraga MS; Ford AA; Greaves MF
Rev Med Chil; 2001 Jun; 129(6):634-42. PubMed ID: 11510203
[TBL] [Abstract][Full Text] [Related]
4. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y
Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
[TBL] [Abstract][Full Text] [Related]
5. Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases.
Borkhardt A; Wuchter C; Viehmann S; Pils S; Teigler-Schlegel A; Stanulla M; Zimmermann M; Ludwig WD; Janka-Schaub G; Schrappe M; Harbott J
Leukemia; 2002 Sep; 16(9):1685-90. PubMed ID: 12200682
[TBL] [Abstract][Full Text] [Related]
6. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
Pui CH; Behm FG; Downing JR; Hancock ML; Shurtleff SA; Ribeiro RC; Head DR; Mahmoud HH; Sandlund JT; Furman WL
J Clin Oncol; 1994 May; 12(5):909-15. PubMed ID: 8164041
[TBL] [Abstract][Full Text] [Related]
7. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.
Sorensen PH; Chen CS; Smith FO; Arthur DC; Domer PH; Bernstein ID; Korsmeyer SJ; Hammond GD; Kersey JH
J Clin Invest; 1994 Jan; 93(1):429-37. PubMed ID: 8282816
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) - a report of the Children's Cancer Group.
Heerema NA; Sather HN; Ge J; Arthur DC; Hilden JM; Trigg ME; Reaman GH
Leukemia; 1999 May; 13(5):679-86. PubMed ID: 10374870
[TBL] [Abstract][Full Text] [Related]
9. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations.
Thirman MJ; Gill HJ; Burnett RC; Mbangkollo D; McCabe NR; Kobayashi H; Ziemin-van der Poel S; Kaneko Y; Morgan R; Sandberg AA
N Engl J Med; 1993 Sep; 329(13):909-14. PubMed ID: 8361504
[TBL] [Abstract][Full Text] [Related]
10. Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Rubnitz JE; Link MP; Shuster JJ; Carroll AJ; Hakami N; Frankel LS; Pullen DJ; Cleary ML
Blood; 1994 Jul; 84(2):570-3. PubMed ID: 8025282
[TBL] [Abstract][Full Text] [Related]
11. Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infant acute leukemia with discrepant molecular and cytogenetic findings.
Watanabe N; Kobayashi H; Ichiji O; Yoshida MA; Kikuta A; Komada Y; Sekine I; Ishida Y; Horiukoshi Y; Tsunematsu Y; Yano M; Nakadate H; Kaneko Y
Leukemia; 2003 May; 17(5):876-82. PubMed ID: 12750700
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological aspects of acute lymphoblastic leukemia in 62 infants: retrospective analysis of the Tokyo Children's Cancer Study Group.
Isoyama K; Okawa H; Hayashi Y; Hanada R; Okimoto Y; Maeda M; Saito T; Tsuchida M; Nakazawa S
Pediatr Int; 1999 Oct; 41(5):477-83. PubMed ID: 10530057
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
[TBL] [Abstract][Full Text] [Related]
15. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities.
Hunger SP; Tkachuk DC; Amylon MD; Link MP; Carroll AJ; Welborn JL; Willman CL; Cleary ML
Blood; 1993 Jun; 81(12):3197-203. PubMed ID: 8389614
[TBL] [Abstract][Full Text] [Related]
16. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
Pui CH; Chessells JM; Camitta B; Baruchel A; Biondi A; Boyett JM; Carroll A; Eden OB; Evans WE; Gadner H; Harbott J; Harms DO; Harrison CJ; Harrison PL; Heerema N; Janka-Schaub G; Kamps W; Masera G; Pullen J; Raimondi SC; Richards S; Riehm H; Sallan S; Sather H; Shuster J; Silverman LB; Valsecchi MG; Vilmer E; Zhou Y; Gaynon PS; Schrappe M
Leukemia; 2003 Apr; 17(4):700-6. PubMed ID: 12682627
[TBL] [Abstract][Full Text] [Related]
17. Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B study.
Stock W; Thirman MJ; Dodge RK; Rowley JD; Diaz MO; Wurster-Hill D; Sobol RE; Davey FR; Larson RA; Westbrook CA
Leukemia; 1994 Nov; 8(11):1918-22. PubMed ID: 7967737
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group.
Heerema NA; Arthur DC; Sather H; Albo V; Feusner J; Lange BJ; Steinherz PG; Zeltzer P; Hammond D; Reaman GH
Blood; 1994 Apr; 83(8):2274-84. PubMed ID: 8161794
[TBL] [Abstract][Full Text] [Related]
19. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.
Hilden JM; Dinndorf PA; Meerbaum SO; Sather H; Villaluna D; Heerema NA; McGlennen R; Smith FO; Woods WG; Salzer WL; Johnstone HS; Dreyer Z; Reaman GH;
Blood; 2006 Jul; 108(2):441-51. PubMed ID: 16556894
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
